Independent Advisor Alliance Johnson & Johnson Transaction History

Independent Advisor Alliance

$2.71 Billion
Q3 2024

A detailed history of Independent Advisor Alliance transactions in Johnson & Johnson stock. As of the latest transaction made, Independent Advisor Alliance holds 87,972 shares of JNJ stock, worth $12.7 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

87,972

Previous 113,382 22.41%

Holding current value

$12.7 Million

Previous $16.6 Million 13.97%

% of portfolio

0.53%

Previous 0.57%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$145.48 - $167.38 $3.7 Million - $4.25 Million	-25,410 Reduced 22.41%	87,972 $14.3 Million
Q2 2024 Aug 12, 2024	SELL	$144.38 - $157.78 $3.92 Million - $4.29 Million	-27,184 Reduced 19.34%	113,382 $16.6 Million
Q1 2024 May 08, 2024	SELL	$155.22 - $162.74 $1.55 Million - $1.62 Million	-9,963 Reduced 6.62%	140,566 $22.2 Million
Q4 2023 Feb 08, 2024	SELL	$145.6 - $158.88 $165,984 - $181,123	-1,140 Reduced 0.75%	150,529 $23.6 Million
Q3 2023 Oct 24, 2023	SELL	$155.75 - $174.48 $259,791 - $291,032	-1,668 Reduced 1.09%	151,669 $23.6 Million
Q2 2023 Jul 28, 2023	BUY	$154.35 - $166.11 $204,822 - $220,427	1,327 Added 0.87%	153,337 $25.4 Million
Q1 2023 May 12, 2023	SELL	$151.05 - $180.26 $1.39 Million - $1.66 Million	-9,235 Reduced 5.73%	152,010 $23.6 Million
Q4 2022 Feb 13, 2023	BUY	$160.2 - $179.79 $937,810 - $1.05 Million	5,854 Added 3.77%	161,245 $28.5 Million
Q3 2022 Nov 04, 2022	SELL	$161.33 - $179.52 $1.27 Million - $1.41 Million	-7,849 Reduced 4.81%	155,391 $25.4 Million
Q2 2022 Aug 04, 2022	BUY	$168.19 - $186.01 $1.53 Million - $1.69 Million	9,109 Added 5.91%	163,240 $29 Million
Q1 2022 May 06, 2022	SELL	$158.14 - $179.59 $567,880 - $644,907	-3,591 Reduced 2.28%	154,131 $27.3 Million
Q4 2021 Feb 11, 2022	BUY	$155.93 - $173.01 $375,791 - $416,954	2,410 Added 1.55%	157,722 $27 Million
Q3 2021 Nov 01, 2021	BUY	$161.5 - $179.47 $683,952 - $760,055	4,235 Added 2.8%	155,312 $25.1 Million
Q2 2021 Aug 12, 2021	SELL	$159.48 - $171.07 $1.91 Million - $2.04 Million	-11,946 Reduced 7.33%	151,077 $24.9 Million
Q1 2021 May 14, 2021	BUY	$153.07 - $170.48 $3.64 Million - $4.05 Million	23,780 Added 17.08%	163,023 $26.8 Million
Q4 2020 Feb 11, 2021	BUY	$137.11 - $157.38 $1.43 Million - $1.64 Million	10,413 Added 8.08%	139,243 $21.9 Million
Q3 2020 Nov 04, 2020	BUY	$140.38 - $153.83 $5.11 Million - $5.59 Million	36,370 Added 39.34%	128,830 $19.2 Million
Q2 2020 Aug 06, 2020	SELL	$128.81 - $155.51 $252,596 - $304,955	-1,961 Reduced 2.08%	92,460 $13 Million
Q1 2020 May 14, 2020	SELL	$111.14 - $153.99 $234,616 - $325,072	-2,111 Reduced 2.19%	94,421 $12.4 Million
Q4 2019 Feb 07, 2020	SELL	$127.5 - $146.44 $528,870 - $607,433	-4,148 Reduced 4.12%	96,532 $14.1 Million
Q3 2019 Nov 12, 2019	SELL	$126.95 - $142.14 $83,533 - $93,528	-658 Reduced 0.65%	100,680 $13 Million
Q2 2019 Aug 12, 2019	BUY	$131.15 - $144.24 $1.13 Million - $1.24 Million	8,611 Added 9.29%	101,338 $13 Million
Q1 2019 May 07, 2019	BUY	$125.72 - $139.79 $332,529 - $369,744	2,645 Added 2.94%	92,727 $13 Million
Q4 2018 Feb 12, 2019	BUY	$122.84 - $147.84 $2.72 Million - $3.27 Million	22,126 Added 32.56%	90,082 $11.6 Million
Q3 2018 Nov 13, 2018	BUY	$121.58 - $142.88 $199,755 - $234,751	1,643 Added 2.48%	67,956 $9.11 Million
Q2 2018 Aug 08, 2018	BUY	$119.4 - $131.76 $506,256 - $558,662	4,240 Added 6.83%	66,313 $7.71 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $483,511 - $572,561	3,865 Added 6.64%	62,073 $7.73 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $754,646 - $825,958	5,751 Added 10.96%	58,208 $8.26 Million
Q3 2017 Nov 15, 2017	BUY	$129.47 - $135.38 $767,368 - $802,397	5,927 Added 12.74%	52,457 $7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	46,530	46,530 $6.12 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $378B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Advisor Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Independent Advisor Alliance with notifications on news.

Account

Independent Advisor Alliance Johnson & Johnson Transaction History